Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hussein Kadhem Al-Hakeim, Qasim Jasim Al-Kaabi & Michael Maes. (2022) High mobility group box 1 and Dickkopf-related protein 1 as biomarkers of glucose toxicity, atherogenicity, and lower β cell function in patients with type 2 diabetes mellitus. Growth Factors 40:5-6, pages 240-253.
Read now
Read now
Shuwen Yue, Ning Xue, Honglei Li, Zhen Chen, Baosheng Huang & Xing Wang. (2020) Isomangiferin Attenuates Renal Injury in Diabetic Mice via Inhibiting Inflammation. Diabetes, Metabolic Syndrome and Obesity 13, pages 4273-4280.
Read now
Read now
Wen-Shuang Sheng, He-Lin Xu, Lei Zheng, Yuan-Di Zhuang, Li-Zhuo Jiao, Jia-Feng Zhou, De-Li ZhuGe, Ting-Ting Chi, Ying-Zheng Zhao & Li Lan. (2018) Intrarenal delivery of bFGF-loaded liposome under guiding of ultrasound-targeted microbubble destruction prevent diabetic nephropathy through inhibition of inflammation. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 373-385.
Read now
Read now
Manoj Kumar Gunasekaran, Anne-Laurence Virama-Latchoumy, Anne-Claire Girard, Cynthia Planesse, Alexis Guérin-Dubourg, Lars Ottosson, Ulf Andersson, Maya Césari, Régis Roche & Laurence Hoareau. (2016) TLR4-dependant pro-inflammatory effects of HMGB1 on human adipocyte. Adipocyte 5:4, pages 384-388.
Read now
Read now
Mohd Imtiaz Nawaz & Ghulam Mohammad. (2015) Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte–endothelial interactions. Journal of Receptors and Signal Transduction 35:4, pages 340-345.
Read now
Read now
Armando Rojas, Ramón Pérez-Castro, Ileana González, Fernando Delgado, Jacqueline Romero & Israel Rojas. (2014) The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity. International Reviews of Immunology 33:1, pages 67-80.
Read now
Read now
Articles from other publishers (126)
Shuai Li, Chunxiang Fan, Xu Li, Shanshan Li, Tianfei Yu, Weiwei Zhang, Tianyi Ma, Ming Zhao, Deshan Li, Wei Xiao & Anshan Shan. (2023) Cannabidiol ameliorates inflammatory response partly by AGE‐RAGE pathway in diabetic mice. Drug Development Research 84:7, pages 1427-1436.
Crossref
Crossref
Aiying Shi, Lu Dong, Yuekun Wu, Xiaoxia Liu, Wanhua Li, Jin Wang, Xuemeng Ji, Huan Lv, Yan Zhang & Shuo Wang. (2023) Long-term ingestion of β-lactoglobulin-bound AGEs induces colonic inflammation by modulating RAGE (TLR4)/MYD88/NF-κB signaling pathway and gut microbiota in mice. Journal of Functional Foods 107, pages 105690.
Crossref
Crossref
Zijing Huang, Wai Kit Chu, Tsz Kin Ng, Shaolang Chen, Jiajian Liang, Chong‐Bo Chen, Yanxuan Xu, Biyao Xie, Shuping Ke, Qingping Liu, Weiqi Chen & Dingguo Huang. (2023)
Protective effects of
nattokinase
against microvasculopathy and neuroinflammation in diabetic retinopathy
. Journal of Diabetes.
Crossref
Crossref
Mateusz Wątroba, Anna D. Grabowska & Dariusz Szukiewicz. (2023) Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood–Brain Barrier and the Risk of Dementia. International Journal of Molecular Sciences 24:12, pages 10069.
Crossref
Crossref
Marwa E. Abdelmageed & Rehab S. Abdelrahman. (2023) Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1/RAGE/TLR4 signaling pathways. Life Sciences 322, pages 121654.
Crossref
Crossref
Huijuan Yang, Zhijie Mei, Weidong Chen, Yan Pan, Lei Liu, Ruiping Zhao, Wenjing Ni, Yanfei Wang & Chengqiu Fei. (2022) Therapeutic efficacy of dapagliflozin on diabetic kidney disease in rats. International Immunopharmacology 113, pages 109272.
Crossref
Crossref
Na Kang, Xiaohang Liu, Kabeer Haneef & Wanli Liu. (2022) Old and new damage‐associated molecular patterns (DAMPs) in autoimmune diseases. Rheumatology & Autoimmunity 2:4, pages 185-197.
Crossref
Crossref
Lu Wang, Hongyun Li, Jiheng Hao, Chao Liu, Jiyue Wang, Jingjun Feng, Zheng Guo, Yulu Zheng, Yanbo Zhang, Hongxiang Li, Liyong Zhang & Haifeng Hou. (2022) Thirty-six months recurrence after acute ischemic stroke among patients with comorbid type 2 diabetes: A nested case-control study. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Yuan Chen, Chao Yu, Shuai Jiang & Li Sun. (2022) Japanese Flounder HMGB1: A DAMP Molecule That Promotes Antimicrobial Immunity by Interacting with Immune Cells and Bacterial Pathogen. Genes 13:9, pages 1509.
Crossref
Crossref
Mengru Liu, Jingwen Zhou, Rui Yin, Hui Yin, Yue Ding, Feng Ma & Li Qian. (2022) The HMGB1 (C106A) mutation inhibits IL-10-producing CD19hiFcγRIIbhi B cell expansion by suppressing STAT3 activation in mice. Frontiers in Immunology 13.
Crossref
Crossref
Usama Abdel Azim Sharaf El Din, Mona Mansour Salem & Dina Ossama Abdulazim. (2022) Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease. Nefrología (English Edition) 42:4, pages 390-403.
Crossref
Crossref
Usama Abdel Azim Sharaf El Din, Mona Mansour Salem & Dina Ossama Abdulazim. (2022) Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease. Nefrología 42:4, pages 390-403.
Crossref
Crossref
Shu Wang, Yu-Guang Guan, Yan-Hua Zhu & Min-Zhong Wang. (2022) Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective. World Journal of Psychiatry 12:6, pages 779-786.
Crossref
Crossref
Jae-ho Jeong, Dong Hoon Lee & Juhyun Song. (2022) HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation. Biomedicine & Pharmacotherapy 150, pages 112933.
Crossref
Crossref
Hongyan Zhan, Hongxia Chen, Zizheng Tang, Shasha Liu, Kangqi Xie & Hui Wang. (2022) SIX1 attenuates inflammation and rheumatoid arthritis by silencing MyD88-dependent TLR1/2 signaling. International Immunopharmacology 106, pages 108613.
Crossref
Crossref
Ravichandran Ramasamy, Alexander Shekhtman & Ann Marie Schmidt. (2022) The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications. International Journal of Molecular Sciences 23:9, pages 4579.
Crossref
Crossref
Hend A. Hamouda, Suzan M. Mansour & Mohammed F. Elyamany. (2021) Vitamin D Combined with Pioglitazone Mitigates Type-2 Diabetes-induced Hepatic Injury Through Targeting Inflammation, Apoptosis, and Oxidative Stress. Inflammation 45:1, pages 156-171.
Crossref
Crossref
Mingjian Li, I. Gusti Surya Chandra Trapika, Suet Yee Sara Tang, Jun-Lae Cho, Yanfei Qi, Chun Guang Li, Yujuan Li, Meicun Yao, Depo Yang, Bowen Liu, Rong Li, Ping Yang, Guoyi Ma, Ping Ren, Xi Huang, Deshan Xie, Shaochao Chen, Min Li, Lan Yang, Ping Leng, Yong Huang & George Q. Li. (2022) Mechanisms and Active Compounds Polysaccharides and Bibenzyls of Medicinal Dendrobiums for Diabetes Management. Frontiers in Nutrition 8.
Crossref
Crossref
Ramya Ravi & Bharathidevi Subramaniam Rajesh. 2022. Updates on Endoplasmic Reticulum [Working Title]. Updates on Endoplasmic Reticulum [Working Title].
Xin Cai, Huajie Zhan, Yuguang Ye, Jinjin Yang, Minghui Zhang, Jing Li & Yuan Zhuang. (2021) Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases. Frontiers in Genetics 12.
Crossref
Crossref
Peng Shao. (2021) MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer’s disease mice via regulation of HMGB1/NF-κB signaling. Brain Research 1766, pages 147511.
Crossref
Crossref
Matthew J. Krinock & Neel S. Singhal. (2021) Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Annals of the New York Academy of Sciences 1495:1, pages 78-98.
Crossref
Crossref
Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers 13:11, pages 2821.
Crossref
Crossref
Brady Anderson, Mary Vue, Nya Gayluak, Sarah Jane Brown, Lynne T. Bemis & Glenn E. SimmonsJr.Jr.. (2021) Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma. Onco 1:1, pages 25-37.
Crossref
Crossref
Song Ren, Longfei Pan, Linqing Yang, Zequn Niu, Liming Wang, Hui Feng & Miao Yuan. (2021) miR-29a-3p transferred by mesenchymal stem cells-derived extracellular vesicles protects against myocardial injury after severe acute pancreatitis. Life Sciences 272, pages 119189.
Crossref
Crossref
Puneet Khandelwal, Amitava Das, Chandan K. Sen, Sangly P. Srinivas, Sashwati Roy & Savita Khanna. (2021) A surfactant polymer wound dressing protects human keratinocytes from inducible necroptosis. Scientific Reports 11:1.
Crossref
Crossref
Bhargav N. Waghela, Foram U. Vaidya, Kishu Ranjan, Abu Sufiyan Chhipa, Budhi Sagar Tiwari & Chandramani Pathak. (2020) AGE-RAGE synergy influences programmed cell death signaling to promote cancer. Molecular and Cellular Biochemistry 476:2, pages 585-598.
Crossref
Crossref
Guodong Ma, Zirong Pan, Linglei Kong & Guanhua Du. (2021) Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: Potential mechanisms, targets, therapeutic drugs and biomarkers. International Immunopharmacology 90, pages 107216.
Crossref
Crossref
Xiaoyun Gou, Junjie Ying, Yan Yue, Xia Qiu, Peng Hu, Yi Qu, Jinhui Li & Dezhi Mu. (2020) The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Luanqian Hu, Yuqi Chen, Tingting Chen, Dan Huang, Shihua Li & Shuna Cui. (2020) A Systematic Study of Mechanism of Sargentodoxa cuneata and Patrinia scabiosifolia Against Pelvic Inflammatory Disease With Dampness-Heat Stasis Syndrome via Network Pharmacology Approach. Frontiers in Pharmacology 11.
Crossref
Crossref
Limin Yang, Lin Zhou, Xiaohui Wang, Wang Wang & Jin Wang. (2020) Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice. International Immunopharmacology 89, pages 106987.
Crossref
Crossref
Siddhartha S. GhoshShobha Ghosh. (2020) HMGB1 (High-Mobility Group Box-1). Arteriosclerosis, Thrombosis, and Vascular Biology 40:11, pages 2561-2563.
Crossref
Crossref
Yongjin Wen, Ling Geng, Lin Zhou, Xueliang Pei, Zhiyuan Yang & Zhiwei Ding. (2020) Betulin alleviates on myocardial inflammation in diabetes mice via regulating Siti1/NLRP3/NF-κB pathway. International Immunopharmacology 85, pages 106653.
Crossref
Crossref
Xueyun Yan, Peier Xu, Le Zhou, Jinyue Lu, Haihua Tang, Yuting Zheng & Huaming Cao. (2020) Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro. IUBMB Life 72:5, pages 931-941.
Crossref
Crossref
Devang M. Patel, Madhura Bose & Mark E. Cooper. (2020) Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease. International Journal of Molecular Sciences 21:6, pages 2218.
Crossref
Crossref
Rocío D. V. Fernández, Ariana Díaz, Bettina Bongiovanni, Georgina Gallucci, Diego Bértola, Walter Gardeñez, Susana Lioi, Yésica Bertolin, Romina Galliano, María L. Bay, Oscar Bottasso & Luciano D'Attilio. (2020) Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity. Frontiers in Endocrinology 11.
Crossref
Crossref
Yang Chen, Fuping Zhang, Di Wang, Lan Li, Haibo Si, Chengshi Wang, Jingping Liu, Younan Chen, Jingqiu Cheng & Yanrong Lu. (2020) Mesenchymal Stem Cells Attenuate Diabetic Lung Fibrosis via Adjusting Sirt3-Mediated Stress Responses in Rats. Oxidative Medicine and Cellular Longevity 2020, pages 1-15.
Crossref
Crossref
Yunzhe Tian, He Li, Xiuxing Liu, Lihui Xie, Zhaohao Huang, Weihua Li, Zhuang Li, Yuan Pan, Xiaoqing Chen & Wenru Su. (2020) Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the Cornea. Biomolecules 10:2, pages 210.
Crossref
Crossref
Rui Gao & Nan Sang. (2020) Quasi-ultrafine particles promote cell metastasis via HMGB1-mediated cancer cell adhesion. Environmental Pollution 256, pages 113390.
Crossref
Crossref
Biscetti, Rando, Nardella, Cecchini, Pecorini, Landolfi & Flex. (2019) High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives. International Journal of Molecular Sciences 20:24, pages 6258.
Crossref
Crossref
Cheng Zhang, Feng Chen, Li Feng, Qun Shan, Gui-Hong Zheng, Yong-Jian Wang, Jun Lu, Shao-Hua Fan, Chun-Hui Sun, Dong-Mei Wu, Meng-Qiu Li, Bin Hu, Qing-Qing Wang, Zi-Feng Zhang & Yuan-Lin Zheng. (2019) FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. Molecular Medicine 25:1.
Crossref
Crossref
Abu Sufiyan Chhipa, Swapnil P. Borse, Ruma Baksi, Sunali Lalotra & Manish Nivsarkar. (2019) Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications. Pathology - Research and Practice 215:11, pages 152643.
Crossref
Crossref
Dilip Kumar, Bernett Lee, Kia Joo Puan, Wendy Lee, Boris San Luis, Nurhashikin Yusof, Anand Kumar Andiappan, Ricardo Del Rosario, Jeremie Poschmann, Pavanish Kumar, Gennaro DeLibero, Amit Singhal, Shyam Prabhakar, Wang De Yun, Michael Poidinger & Olaf Rötzschke. (2019) Resistin expression in human monocytes is controlled by two linked promoter SNPs mediating NFKB p50/p50 binding and C-methylation. Scientific Reports 9:1.
Crossref
Crossref
Constanze C. Maresch, Dina C. Stute, Thomas Fleming, Jihong Lin, Hans-Peter Hammes & Thomas Linn. (2019) Hyperglycemia induces spermatogenic disruption via major pathways of diabetes pathogenesis. Scientific Reports 9:1.
Crossref
Crossref
Jitao Guo, Elena Muse, Allison J. Christians, Steven J. Swanson & Eduardo Davila. (2019) An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine. Cancer Immunology Research 7:9, pages 1523-1534.
Crossref
Crossref
Minzaghi, Pavel & Dubrac. (2019) Xenobiotic Receptors and Their Mates in Atopic Dermatitis. International Journal of Molecular Sciences 20:17, pages 4234.
Crossref
Crossref
Yanbin Wang, Zhaoqiang Jiang, Jianing Yan & Shibo Ying. (2019) HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma. Disease Markers 2019, pages 1-10.
Crossref
Crossref
Armando Rojas, Miguel Morales, Ileana Gonzalez & Paulina Araya. (2019) Inhibition of RAGE Axis Signaling: A Pharmacological Challenge. Current Drug Targets 20:3, pages 340-346.
Crossref
Crossref
Ivan Koprivica, Milica Vujičić, Dragica Gajić, Tamara Saksida & Ivana Stojanović. (2019) Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice. Frontiers in Immunology 9.
Crossref
Crossref
Hae Young Chung, Dae Hyun Kim, Eun Kyeong Lee, Ki Wung Chung, Sangwoon Chung, Bonggi Lee, Arnold Y. Seo, Jae Heun Chung, Young Suk Jung, Eunok Im, Jaewon Lee, Nam Deuk Kim, Yeon Ja Choi, Dong Soon Im & Byung Pal Yu. (2019) Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept. Aging and disease 10:2, pages 367.
Crossref
Crossref
Masako Toda, Michael Hellwig, Thomas Henle & Stefan Vieths. (2019) Influence of the Maillard Reaction on the Allergenicity of Food Proteins and the Development of Allergic Inflammation. Current Allergy and Asthma Reports 19:1.
Crossref
Crossref
Kathleen R. Heim, Melissa J. Mulla, Julie A. Potter, Christina S. Han, Seth Guller & Vikki M. Abrahams. (2018) Excess glucose induce trophoblast inflammation and limit cell migration through HMGB1 activation of Toll-Like receptor 4. American Journal of Reproductive Immunology 80:5, pages e13044.
Crossref
Crossref
Ronghua Hu, Chang-Qing Xia, Edward Butfiloski & Michael Clare-Salzler. (2018) Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clinical Immunology 195, pages 139-148.
Crossref
Crossref
Rosalinda Madonna, Damiana Pieragostino, Carmela Rita Balistreri, Claudia Rossi, Yong-Jian Geng, Piero Del Boccio & Raffaele De Caterina. (2018) Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage. Vascular Pharmacology 107, pages 27-34.
Crossref
Crossref
Qin Xu, Xia Liu, Liyan Mei, Quan Wen, Jing Chen, Jifei Miao, Hang Lei, Huina Huang, Dongfeng Chen, Shaohui Du, Aijun Liu, Saixia Zhang, Jianhong Zhou, Rudong Deng, Yiwei Li, Chun Li & Hui Li. (2018) Paeonol Reduces the Nucleocytoplasmic Transportation of HMGB1 by Upregulating HDAC3 in LPS-Induced RAW264.7 Cells. Inflammation 41:4, pages 1536-1545.
Crossref
Crossref
Xiao‐Jin Wu, Yuan‐Yuan Chen, Chan‐Chan Gong & Dong‐Sheng Pei. (2018) The role of high‐mobility group protein box 1 in lung cancer. Journal of Cellular Biochemistry 119:8, pages 6354-6365.
Crossref
Crossref
Maoliang Huang, Yan Geng, Qiaoting Deng, Ru Li, Xiangyang Shao, Zhigao Zhang, Weiwen Xu, Yingsong Wu & Qiang Ma. (2018) Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway. International Journal of Oncology.
Crossref
Crossref
Shuai Shao, Yue Gao, Jianxiang Liu, Mei Tian, Qiao Gou & Xu Su. (2018) Ferulic Acid Mitigates Radiation Injury in Human Umbilical Vein Endothelial Cells In Vitro via the Thrombomodulin Pathway. Radiation Research 190:3, pages 298.
Crossref
Crossref
Ji Hae Jun, Jong Wook Song, Eun-Jung Shin, Young-Lan Kwak, Nakcheol Choi & Jae-Kwang Shim. (2018) Ethyl pyruvate is renoprotective against ischemia-reperfusion injury under hyperglycemia. The Journal of Thoracic and Cardiovascular Surgery 155:4, pages 1650-1658.
Crossref
Crossref
P. Ai, X. Zhang, Z. Xie, G. Liu, X. Liu, S. Pan & H. Wang. (2017)
The
HMGB
1 is increased in
CSF
of patients with an Anti‐
NMDAR
encephalitis
. Acta Neurologica Scandinavica 137:2, pages 277-282.
Crossref
Crossref
Sarah Soh, Ji Hae Jun, Jong Wook Song, Eun-Jung Shin, Young-Lan Kwak & Jae-Kwang Shim. (2018) Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1. International Journal of Cardiology 252, pages 156-162.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerStig Bengmark. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
1609
1660
.
Silvia Giovannini, Giovanni Tinelli, Federico Biscetti, Giuseppe Straface, Flavia Angelini, Dario Pitocco, Luciana Mucci, Raffaele Landolfi & Andrea Flex. (2017) Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects. Cardiovascular Diabetology 16:1.
Crossref
Crossref
Xinxin Liu, Xin Wang, Xiaoru Duan, Devesh Poorun, Juntao Xu, Song Zhang, Lu Gan, Mengwen He, Ke Zhu, Zhangyin Ming, Feng Hu & Hongxiang Chen. (2017) Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis. Scientific Reports 7:1.
Crossref
Crossref
Hongliu Chen, Zong Ning, Ying Qiu, Yuanli Liao, Haihua Chang, Yuanyuan Ai, Yinghua Wei, Yiming Deng & Ying Shen. (2017) Elevated levels of von Willebrand factor and high mobility group box 1 (HMGB1) are associated with disease severity and clinical outcome of scrub typhus. International Journal of Infectious Diseases 61, pages 114-120.
Crossref
Crossref
Trevor HardiganCaterina HernandezRebecca WardM. Nasrul Hoda & Adviye Ergul. (2017) TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 312:6, pages R927-R937.
Crossref
Crossref
Shibo Ying, Zhaoqiang Jiang, Xianglei He, Min Yu, Riping Chen, Junqiang Chen, Guoqing Ru, Yuan Chen, Wanyuan Chen, Lijin Zhu, Tao Li, Yixiao Zhang, Xinnian Guo, Xianhong Yin, Xing Zhang & Jianlin Lou. (2017) Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. Disease Markers 2017, pages 1-9.
Crossref
Crossref
J.Q. Tao, E.M. Sorokina, J.P. Vazquez Medina, M.K. Mishra, Y. Yamada, J. Satalin, G.F. Nieman, J.R. Nellen, B. Beduhn, E. Cantu, N.M. Habashi, W. Jungraithmayr, J.D. Christie & S. Chatterjee. (2016) Onset of Inflammation With Ischemia: Implications for Donor Lung Preservation and Transplant Survival. American Journal of Transplantation 16:9, pages 2598-2611.
Crossref
Crossref
Ramkumar Menon, Elizabeth A Bonney, Jennifer Condon, Sam Mesiano & Robert N Taylor. (2016) Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Human Reproduction Update 22:5, pages 535-560.
Crossref
Crossref
Kuei-Chang Li, Hsun-Chen Chu, Yow Lin, Hsing-Yu Tuan & Yu-Chen Hu. (2016) PEGylated Copper Nanowires as a Novel Photothermal Therapy Agent. ACS Applied Materials & Interfaces 8:19, pages 12082-12090.
Crossref
Crossref
A. Giacobbe, R. Granese, R. Grasso, V. Salpietro, F. Corrado, G. Giorgianni, G. Foti, D. Amadore, O. Triolo, L. Giunta & A. Di Benedetto. (2016) Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 26:5, pages 414-418.
Crossref
Crossref
Eduardo Fuentes, Iván Palomo & Armando Rojas. (2016) Cross-talk between platelet and tumor microenvironment: Role of multiligand/RAGE axis in platelet activation. Blood Reviews 30:3, pages 213-221.
Crossref
Crossref
Petra Tesarova, Marta Kalousova, Tomas Zima & Vladimir Tesar. (2016) HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets. Biomedical Papers 160:1, pages 1-10.
Crossref
Crossref
Jürgen M. Overath, Stefan Gauer, Nicholas Obermüller, Ralf Schubert, Richard Schäfer, Helmut Geiger & Patrick C. Baer. (2016) Short-term preconditioning enhances the therapeutic potential of adipose-derived stromal/stem cell-conditioned medium in cisplatin-induced acute kidney injury. Experimental Cell Research 342:2, pages 175-183.
Crossref
Crossref
Armando Rojas, Fernando Delgado-López, Ramón Perez-Castro, Ileana Gonzalez, Jacqueline Romero, Israel Rojas, Paulina Araya, Carolina Añazco, Erik Morales & Jorge Llanos. (2015) HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumor Biology 37:3, pages 3321-3329.
Crossref
Crossref
Liang Feng, Mao-mao Zhu, Wei-quan Bu, Chun-fei Wang, Zhao-guang Zheng, Ru-shang Wang, Xiao-bin Jia & Quan Zhu. (2016) The C-terminal tails of 4,4'-diphenylmethane-bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products-induced inflammation and apoptosis responses in human umbilical vein endothelial cells. Journal of Pharmacy and Pharmacology 68:1, pages 93-106.
Crossref
Crossref
Shibo Ying, Xiang Xiao, Tianhui Chen & Jianlin Lou. (2016) PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1. PPAR Research 2016, pages 1-10.
Crossref
Crossref
Yanan Wang, Jixin Zhong, Xiangzhi Zhang, Ziwei Liu, Yuan Yang, Quan Gong & Boxu Ren. (2016) The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes. Journal of Diabetes Research 2016, pages 1-11.
Crossref
Crossref
T. Sree Latha, Dakshayani Lomada, Praveen Kumar Dharani, Shankar V. Muthukonda & Madhava C. Reddy. (2016) Ti–O based nanomaterials ameliorate experimental autoimmune encephalomyelitis and collagen-induced arthritis. RSC Advances 6:11, pages 8870-8880.
Crossref
Crossref
Jingjing CaiJuan WenEileen BauerHua ZhongHong YuanAlex F. Chen. (2015) The Role of HMGB1 in Cardiovascular Biology: Danger Signals. Antioxidants & Redox Signaling 23:17, pages 1351-1369.
Crossref
Crossref
Ker Zhing Lok, Milan Basta, Silvia Manzanero & Thiruma V Arumugam. (2015) Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia. Journal of Neuroinflammation 12:1.
Crossref
Crossref
S L Yu, C K WongC C Szeto, E K Li, Z CaiL S Tam. (2014) Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus 24:7, pages 675-686.
Crossref
Crossref
Vengadeshprabhu Karuppagounder, Somasundaram Arumugam, Rajarajan A. Thandavarayan, Vigneshwaran Pitchaimani, Remya Sreedhar, Rejina Afrin, Meilei Harima, Hiroshi Suzuki, Mayumi Nomoto, Shizuka Miyashita, Kenji Suzuki, Masahiko Nakamura & Kenichi Watanabe. (2015)
Modulation of HMGB1 translocation and RAGE/NF
κ
B cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice
. Experimental Dermatology 24:6, pages 418-423.
Crossref
Crossref
Barbara CapuaniDavid Della-Morte, Giulia DonadelSara CaratelliLuca BovaDonatella PastoreMichele De CanioSimona D'AguannoAndrea CoppolaFrancesca PacificiRoberto ArrigaAlfonso BelliaFrancesca FerrelliManfredi TesauroMassimo FedericiAnna NeriSergio BernardiniPaolo SbracciaNicola Di DanieleGiuseppe Sconocchia, Augusto OrlandiAndrea UrbaniDavide Lauro. (2015) Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. American Journal of Physiology-Endocrinology and Metabolism 308:9, pages E744-E755.
Crossref
Crossref
Suhashini S. Dhumale, Bhargav N. Waghela & Chandramani Pathak. (2015) Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. IUBMB Life 67:5, pages 361-373.
Crossref
Crossref
Lei Zhen, De-sheng Fan, Yan Zhang, Xin-ming Cao & Li-ming Wang. (2014) Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling. Acta Pharmacologica Sinica 36:2, pages 221-228.
Crossref
Crossref
Jianxing Luo, Yang Zhang, Xiaoyu Hu, Sen Zhong, Guo Chen, Yanyan Wang, Wu Lin, Cheng Yi & Hong Zhu. (2015) The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by d-galactosamine in rats. Journal of Ethnopharmacology 161, pages 53-59.
Crossref
Crossref
Xi Yang, Jincai Zhang, Jia Ni, Bin Ouyang, Dan Wang, Shigao Luo, Baoyi Xie & Dongying Xuan. (2014) Toll-Like Receptor 4–Mediated Hyper-Responsiveness of Gingival Epithelial Cells to Lipopolysaccharide in High-Glucose Environments. Journal of Periodontology 85:11, pages 1620-1628.
Crossref
Crossref
Wai Han Yiu, Miao Lin & Sydney C.W. Tang. (2014) Toll-like receptor activation: from renal inflammation to fibrosis. Kidney International Supplements 4:1, pages 20-25.
Crossref
Crossref
HUI WENG, HONGBO LIU, YUNHUA DENG, YUYAN XIE & GUANXIN SHEN. (2014) Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus. Molecular Medicine Reports 10:4, pages 1765-1771.
Crossref
Crossref
Jingjing Li, Meiping Guan, Chenzhong Li, Fuping Lyv, Yanmei Zeng, Zongji Zheng, Chengzhi Wang & Yaoming Xue. (2014) The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Protects against Dyslipidemia-Related Kidney Injury in Apolipoprotein E Knockout Mice. International Journal of Molecular Sciences 15:7, pages 11416-11434.
Crossref
Crossref
A. S. Reece & G. K. Hulse. (2014) Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women. BMJ Open 4:6, pages e004521-e004521.
Crossref
Crossref
X. Xu, H. Zhu, T. Wang, Y. Sun, P. Ni, Y. Liu, S. Tian, P. Amoah Barnie, H. Shen, W. Xu, H. Xu & Z. Su. (2014) Exogenous High-Mobility Group Box 1 Inhibits Apoptosis and Promotes the Proliferation of Lewis Cells via RAGE/TLR4-Dependent Signal Pathways. Scandinavian Journal of Immunology 79:6, pages 386-394.
Crossref
Crossref
Harshini Mudaliar, Carol Pollock & Usha Panchapakesan. (2014) Role of Toll-like receptors in diabetic nephropathy. Clinical Science 126:10, pages 685-694.
Crossref
Crossref
Sae-Kwang Ku, In-Chul Lee, Jeong Ah Kim & Jong-Sup Bae. (2013) Anti-septic Effects of Pellitorine in HMGB1-Induced Inflammatory Responses In Vitro and In Vivo. Inflammation 37:2, pages 338-348.
Crossref
Crossref
Li Jia, Andrew Clear, Feng-Ting Liu, Janet Matthews, Nadiha Uddin, Aine McCarthy, Elena Hoxha, Catherine Durance, Sameena Iqbal & John G. Gribben. (2014) Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia. Blood 123:11, pages 1709-1719.
Crossref
Crossref
Monika Heilmann, Anne Wellner, Gabriele Gadermaier, Anne Ilchmann, Peter Briza, Maren Krause, Ryoji Nagai, Sven Burgdorf, Stephan Scheurer, Stefan Vieths, Thomas Henle & Masako Toda. (2014) Ovalbumin Modified with Pyrraline, a Maillard Reaction Product, shows Enhanced T-cell Immunogenicity. Journal of Biological Chemistry 289:11, pages 7919-7928.
Crossref
Crossref
Eduardo Fuentes, Armando Rojas & Iván Palomo. (2014) Role of multiligand/RAGE axis in platelet activation. Thrombosis Research 133:3, pages 308-314.
Crossref
Crossref
Domenica Musumeci, Giovanni N. Roviello & Daniela Montesarchio. (2014) An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacology & Therapeutics 141:3, pages 347-357.
Crossref
Crossref
Jérôme Lugrin, Nathalie Rosenblatt-Velin, Roumen Parapanov & Lucas Liaudet. (2014) The role of oxidative stress during inflammatory processes. Biological Chemistry 395:2, pages 203-230.
Crossref
Crossref
Binna Oh & Minhyung Lee. (2014) Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury. Journal of Controlled Release 175, pages 25-35.
Crossref
Crossref
Arthur Lau, Shuang Wang, Weihua Liu, Aaron Haig, Zhu-Xu Zhang & Anthony M. Jevnikar. (2014) Glycyrrhizic Acid Ameliorates HMGB1-Mediated Cell Death and Inflammation after Renal Ischemia Reperfusion Injury. American Journal of Nephrology 40:1, pages 84-95.
Crossref
Crossref
Karim H. Shalaby. 2014. Immunology of Aging. Immunology of Aging
87
143
.
Dohoung Kim, In-Young Choi, Hyunduk Jang & Seung-Hoon Lee. (2013) HMGB1 suppression confers neuroprotection against stroke in diabetic rats. Translational Neuroscience 4:4, pages 477-483.
Crossref
Crossref
Hui Weng, Yunhua Deng, Yuyan Xie, Hongbo Liu & Feili Gong. (2013) Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors. BMC Cancer 13:1.
Crossref
Crossref
Maowei Wang, Yan Yue, Chunsheng Dong, Xiaoyun Li, Wei Xu & Sidong Xiong. (2013) Mucosal Immunization with High-Mobility Group Box 1 in Chitosan Enhances DNA Vaccine-Induced Protection against Coxsackievirus B3-Induced Myocarditis. Clinical and Vaccine Immunology 20:11, pages 1743-1751.
Crossref
Crossref
Qian-Qian Jia, Jian-Cheng Wang, Jing Long, Yan Zhao, Si-Jia Chen, Jia-Dai Zhai, Lian-Bo Wei, Quan Zhang, Yue Chen & Hai-Bo Long. (2013) Sesquiterpene Lactones and Their Derivatives Inhibit High Glucose-Induced NF-κB Activation and MCP-1 and TGF-β1 Expression in Rat Mesangial Cells. Molecules 18:10, pages 13061-13077.
Crossref
Crossref
Harshini Mudaliar, Carol Pollock, Muralikrishna Gangadharan Komala, Steven Chadban, Huiling Wu & Usha Panchapakesan. (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. American Journal of Physiology-Renal Physiology 305:2, pages F143-F154.
Crossref
Crossref
Fu-ping Wang, Lei Li, Jing Li, Ji-yao Wang, Ling-yan Wang & Wei Jiang. (2013) High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK. PLoS ONE 8:5, pages e64373.
Crossref
Crossref
Ruzena Sotnikova, Ludmila Okruhlicova, Jana Vlkovicova, Jana Navarova, Beata Gajdacova, Lenka Pivackova, Silvia Fialova & Peter Krenek. (2013) Rosmarinic acid administration attenuates diabetes-induced vascular dysfunction of the rat aorta. Journal of Pharmacy and Pharmacology 65:5, pages 713-723.
Crossref
Crossref
Stig Bengmark. (2013) Gut microbiota, immune development and function. Pharmacological Research 69:1, pages 87-113.
Crossref
Crossref
Armando Rojas, Fernando Delgado-López, Ileana González, Ramón Pérez-Castro, Jacqueline Romero & Israel Rojas. (2013) The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor. Cellular Signalling 25:3, pages 609-614.
Crossref
Crossref
Liang Feng, Maomao Zhu, Minghua Zhang, Xiaobin Jia, Xudong Cheng, Shumin Ding & Quan Zhu. (2013) Amelioration of compound 4,4′-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway. International Immunopharmacology 15:2, pages 206-216.
Crossref
Crossref
Ghulam Mohammad, Mohammad Mairaj Siddiquei, Amira Othman, Mohamed Al-Shabrawey & Ahmed M. Abu El-Asrar. (2013) High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Experimental Eye Research 107, pages 101-109.
Crossref
Crossref
Honghao Wang, Kai Wang, Conghui Wang, Fangcheng Xu, Xiaonan Zhong, Wei Qiu & Xueqiang Hu. (2013) Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis. Neuroimmunomodulation 20:2, pages 113-118.
Crossref
Crossref
Kanhaiya Singh, Vivek Kumar Singh, Neeraj K. Agrawal, Sanjeev K. Gupta & Kiran Singh. (2013) Association of Toll-Like Receptor 4 Polymorphisms with Diabetic Foot Ulcers and Application of Artificial Neural Network in DFU Risk Assessment in Type 2 Diabetes Patients. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Munirathinam Gnanasekar, Ramaswamy Kalyanasundaram, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland & André Kajdacsy-Balla. (2013) HMGB1: A Promising Therapeutic Target for Prostate Cancer. Prostate Cancer 2013, pages 1-8.
Crossref
Crossref
Josephine M. Forbes & Mark E. Cooper. (2013) Mechanisms of Diabetic Complications. Physiological Reviews 93:1, pages 137-188.
Crossref
Crossref
Usha Panchapakesan, Amanda Mather & Carol Pollock. (2012) Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease. Clinical Science 124:1, pages 17-26.
Crossref
Crossref
Eileen M Bauer, Richard Shapiro, Han Zheng, Ferhaan Ahmad, David Ishizawar, Suzy A Comhair, Serpil C Erzurum, Timothy R Billiar & Philip M Bauer. (2012) High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4. Molecular Medicine 18:12, pages 1509-1518.
Crossref
Crossref
Felipe Dal-Pizzol, Matheus Pasquali, João Quevedo, Daniel Pens Gelain & José Cláudio Fonseca Moreira. (2012) Is There a Role for High Mobility Group Box 1 and the Receptor for Advanced Glycation End Products in the Genesis of Long-term Cognitive Impairment in Sepsis Survivors?. Molecular Medicine 18:10, pages 1357-1358.
Crossref
Crossref
Peng-Cheng Ren, Yong Zhang, Xu-Dong Zhang, Li-Jun An, Hai-Gang Lv, Jun He, Chang-Jun Gao & Xu-De Sun. (2012) High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Research Bulletin 88:4, pages 332-337.
Crossref
Crossref
Min LiLujun SongXiaodong GaoWenju ChangXinyu Qin. (2012) Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Experimental & Molecular Medicine 44:4, pages 260.
Crossref
Crossref
Takhellambam S. Devi, Icksoo Lee, Maik Hüttemann, Ashok Kumar, Kwaku D. Nantwi & Lalit P. Singh. (2012) TXNIP Links Innate Host Defense Mechanisms to Oxidative Stress and Inflammation in Retinal Muller Glia under Chronic Hyperglycemia: Implications for Diabetic Retinopathy. Experimental Diabetes Research 2012, pages 1-19.
Crossref
Crossref
Liang Feng, You-hua Xu, Shan-shan Wang, Wai Au-yeung, Zhao-guang Zheng, Quan Zhu & Ping Xiang. (2012) Competitive binding between 4,4′-diphenylmethane-bis(methyl) carbamate and RAGE ligand MG-H1 on human umbilical vein endothelial cell by cell membrane chromatography. Journal of Chromatography B 881-882, pages 55-62.
Crossref
Crossref
Zijing Huang, Xiaowei Sun, Wai Kit Chu, Tsz Kin Ng, Shaolang Chen, Jiajian Liang, Chongbo Chen, Yanxuan Xu, Qingping Liu, Weiqi Chen & Dingguo Huang. (2022) Protective Effects of Nattokinase Against Microvascular Abnormalities and Neuroinflammation by Regulating HMGB1 Signaling in Diabetic Retinopathy. SSRN Electronic Journal.
Crossref
Crossref